ArticleMolecular cancer therapeutics2025

Navitoclax, a Bcl-2/xL Inhibitor, and YM155, a Survivin Inhibitor, in Combination with Carboplatin, Effectively Inhibit Ovarian Cancer Tumor Growth.

Hilary A Kenny et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.